Stephanie Propp
Ionis Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
DNA and Nucleic Acid Chemistry, Microtubule and mitosis dynamics, Genetics, Bioinformatics, and Biomedical Research, Monoclonal and Polyclonal Antibodies Research, Genetic Neurodegenerative Diseases
Most-Cited Works
- → miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting(2006)2,050 cited
- → Caspase Cleavage of Gene Products Associated with Triplet Expansion Disorders Generates Truncated Fragments Containing the Polyglutamine Tract(1998)568 cited
- → Kennedy's Disease(1999)242 cited
- → Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease(2004)221 cited
- → Potent inhibition of microRNA in vivo without degradation(2008)196 cited
- → SAR by MS: Discovery of a New Class of RNA-Binding Small Molecules for the Hepatitis C Virus: Internal Ribosome Entry Site IIA Subdomain(2005)173 cited
- → Competition for RISC binding predicts in vitro potency of siRNA(2006)118 cited
- → Cleavage of Atrophin-1 at Caspase Site Aspartic Acid 109 Modulates Cytotoxicity(1999)111 cited
- → Proteolytic Cleavage of Ataxin-7 by Caspase-7 Modulates Cellular Toxicity and Transcriptional Dysregulation(2007)89 cited
- → Use of a Chemically Modified Antisense Oligonucleotide Library to Identify and Validate Eg5 (Kinesin-Like 1) as a Target for Antineoplastic Drug Development(2006)45 cited